Medical Ikkou Co., Ltd. agreed to acquire Efa Co., Ltd from Nakagawa Sangyo Co.,Ltd and Takashi Nakagawa.
February 25, 2018
Share
Medical Ikkou Co., Ltd. (JASDAQ:3353) agreed to acquire Efa Co., Ltd from Nakagawa Sangyo Co.,Ltd and Takashi Nakagawa on February 26, 2018. Under the terms, Medical Ikkou Co., Ltd will acquire 200 shares of Efa Co., Ltd. Nakagawa Sangyo Co.,Ltd and Takashi Nakagawa holds 50% stake each in Efa Co., Ltd. Contract will be signed on March 1, 2018. For the fiscal year ended June 2017, Efa Co., Ltd reported net assets of ¥112 million, total assets of ¥262 million, sales of ¥806 million, operating income of ¥10 million and net income of ¥7 million. The transaction is resolved by the Board of Directors of Medical Ikkou Co., Ltd on February 27, 2018. The transaction is expected to close on March 1, 2018.
Medical Ikkou Group Co.,Ltd. is a Japan-based company mainly engaged in the operation of dispensing pharmacies that fill prescriptions for general patients based on the medical prescriptions issued by medical institutions. The Company operates in four business segments. The Dispensing Pharmacy segment is specialized in the sale of medical drugs based on medical prescriptions. The Healthcare segment is engaged in the operation of nursing care facilities, the leasing of medical facilities and others, as well as the medical care and nursing care related businesses. The Medicine Wholesale segment is engaged in the sale of pharmaceutical products to medical institutions and others. The Real Estate segment is engaged in the leasing of real estate properties.
MEDICAL IKKOU GROUP CO.,LTD. 